venetoclax,tamibarotene,azacitidine
tmrc,zeria pharmaceuticals,syros ,syros,nippon shinyaku,roche,abbvie
['select,aml-1', 'tamibarotene', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', '$syrs']
 #ash22 starts today! very excited for the &gt;50 smid-cap biopharmas presenting data company spotlight: $syrs presenting initial ph2 select-aml-1 data from tamibarotene trial today @ 5:30pm ct see all pres. in our blog: $xbi $ibb #biotech
FDA Catalyst Calendar, Big Mover™ stocks to watch, & Model Portfolios. Database & tools to make you a profitable biotech stock investor. Try Free https://t.co/5njnanr11i